These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 30827925

  • 1. Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities.
    Önnerhag K, Dreja K, Nilsson PM, Lindgren S.
    Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):542-550. PubMed ID: 30827925
    [Abstract] [Full Text] [Related]

  • 2. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
    Önnerhag K, Hartman H, Nilsson PM, Lindgren S.
    Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
    [Abstract] [Full Text] [Related]

  • 3. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
    Önnerhag K, Nilsson PM, Lindgren S.
    Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
    [Abstract] [Full Text] [Related]

  • 4. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R, Ritchie J, Green D, Kalra PA.
    Nephrol Dial Transplant; 2019 Mar 01; 34(3):449-457. PubMed ID: 29390103
    [Abstract] [Full Text] [Related]

  • 5. Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?
    Zhang M, Lin S, Wang MF, Huang JF, Liu SY, Wu SM, Zhang HY, Wu ZM, Liu WY, Zhang DC, Hao CM, Zhu YY, Zheng MH, Wang XZ.
    BMC Gastroenterol; 2020 May 06; 20(1):139. PubMed ID: 32375660
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The correlation between fatty liver disease and chronic kidney disease.
    Chen PC, Kao WY, Cheng YL, Wang YJ, Hou MC, Wu JC, Su CW.
    J Formos Med Assoc; 2020 Jan 06; 119(1 Pt 1):42-50. PubMed ID: 30876789
    [Abstract] [Full Text] [Related]

  • 9. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H, Dawwas GK, Liu X, Nguyen MH.
    J Intern Med; 2019 Dec 06; 286(6):711-722. PubMed ID: 31359543
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
    Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.
    Metabolism; 2018 Feb 06; 79():64-76. PubMed ID: 29137912
    [Abstract] [Full Text] [Related]

  • 11. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD).
    Roderburg C, Krieg S, Krieg A, Demir M, Luedde T, Kostev K, Loosen SH.
    Eur J Med Res; 2023 Apr 17; 28(1):153. PubMed ID: 37062837
    [Abstract] [Full Text] [Related]

  • 12. MAFLD and risk of CKD.
    Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, Targher G, Byrne CD, Yuan WJ, Zheng MH.
    Metabolism; 2021 Feb 17; 115():154433. PubMed ID: 33212070
    [Abstract] [Full Text] [Related]

  • 13. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K, Thongprayoon C, Scribani M, Ungprasert P, Cheungpasitporn W.
    Eur J Gastroenterol Hepatol; 2018 Apr 17; 30(4):404-410. PubMed ID: 29215435
    [Abstract] [Full Text] [Related]

  • 14. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.
    Hydes TJ, Kennedy OJ, Buchanan R, Cuthbertson DJ, Parkes J, Fraser SDS, Roderick P.
    BMC Med; 2023 May 18; 21(1):185. PubMed ID: 37198624
    [Abstract] [Full Text] [Related]

  • 15. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
    Bellinato F, Goio I, Malara G, Rosato A, Targher G, Girolomoni G, Gisondi P.
    J Cutan Med Surg; 2022 May 18; 26(3):249-255. PubMed ID: 34894782
    [Abstract] [Full Text] [Related]

  • 16. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
    Zuo G, Xuan L, Xin Z, Xu Y, Lu J, Chen Y, Dai M, Zhang D, Wang W, Li M, Bi Y, Ning G, Xu M.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e3957-e3968. PubMed ID: 34125886
    [Abstract] [Full Text] [Related]

  • 17. FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease.
    Seko Y, Yano K, Takahashi A, Okishio S, Kataoka S, Okuda K, Mizuno N, Takemura M, Taketani H, Umemura A, Nishikawa T, Yamaguchi K, Moriguchi M, Okanoue T, Itoh Y.
    Int J Mol Sci; 2019 Dec 25; 21(1):. PubMed ID: 31881781
    [Abstract] [Full Text] [Related]

  • 18. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    Huh JH, Kim JY, Choi E, Kim JS, Chang Y, Sung KC.
    PLoS One; 2017 Dec 25; 12(7):e0180951. PubMed ID: 28738057
    [Abstract] [Full Text] [Related]

  • 19. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
    Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, Hultcrantz R, Hagström H, Yoon SK, Charatcharoenwitthaya P, George J, Barrera F, Hafliðadóttir S, Björnsson ES, Armstrong MJ, Hopkins LJ, Gao X, Francque S, Verrijken A, Yilmaz Y, Lindor KD, Charlton M, Haring R, Lerch MM, Rettig R, Völzke H, Ryu S, Li G, Wong LL, Machado M, Cortez-Pinto H, Yasui K, Cassader M.
    PLoS Med; 2014 Jul 25; 11(7):e1001680. PubMed ID: 25050550
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease.
    Sun C, Goh GB, Chow WC, Chan WK, Wong GL, Seto WK, Huang YH, Lin HC, Lee IC, Lee HW, Kim SU, Wong VW, Fan JG.
    Hepatobiliary Pancreat Dis Int; 2024 Jun 25; 23(3):241-248. PubMed ID: 37620227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.